Intratumoral Delivery of Dendritic Cells Plus Anti-Her2 Therapy Triggers Both Robust Systemic Antitumor Immunity and Complete Regression in HER2 Mammary Carcinoma.
Journal for ImmunoTherapy of Cancer（2022）
Key words
immunotherapy,dendritic cells,CD4-positive T-lymphocytes,B-lymphocytes,natural killer T-cells
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined